Wegovy vs. Zepbound: Cost Comparison
Wegovy and Zepbound sit in a similar price range, but they're not the same drug, and the cost difference doesn't tell you which one fits you.
Two different drugs, similar price bracket
Wegovy is semaglutide; Zepbound is tirzepatide. They're both GLP-1 medications approved for chronic weight management, and at retail they tend to land in the same $400–$800/mo range as the rest of the category, which makes them easy to treat as interchangeable when the only thing being compared is the sticker price.
What the cost difference doesn't tell you
Semaglutide and tirzepatide act on different receptor pathways, and clinical trial data has shown different average weight-loss outcomes between them, but that's a clinical question, not a pricing one. A lower price on one doesn't make it the better fit for you; that's determined by your labs, history, and tolerance, reviewed by a licensed clinician.
Retail range vs. member pricing
Basecare's Premier membership prices the GLP-1 weight care program itself, not one specific drug, at up to 40% below the average retail range for the category. That means the member price is the same whether your clinician determines Wegovy, Zepbound, or another option is appropriate, so the drug decision and the price decision stay separate.
What actually decides which one you're prescribed
Neither Wegovy nor Zepbound is prescribed by price. Your clinician reviews your labs, medical history, and goals through the Altro Health portal and determines which medication, if any, is clinically appropriate, before anything is prescribed.
Bottom line
Wegovy and Zepbound cost roughly the same at retail, but that's a coincidence of the category, not a reason to pick one over the other. Compare the program price, not just the drug price, and let your clinician's assessment, not the number on a landing page, decide which medication fits.
GENERAL COST AND MEMBERSHIP INFORMATION, NOT MEDICAL ADVICE · PRICING ILLUSTRATIVE, CONFIRM YOUR EXACT MEMBER PRICE BEFORE CHECKOUT